Chris Robertson

Active 1986–2025

159
Papers
20,936
Citations
83
h-index
149
i10-index

Citations

Citations per year for Chris Robertson1928: 2 citations1982: 1 citations1987: 2 citations1988: 1 citations1991: 2 citations1997: 2 citations1998: 1 citations1999: 5 citations2000: 13 citations2001: 32 citations2002: 35 citations2003: 84 citations2004: 58 citations2005: 98 citations2006: 72 citations2007: 73 citations2008: 68 citations2009: 94 citations2010: 82 citations2011: 84 citations2012: 76 citations2013: 95 citations2014: 76 citations2015: 90 citations2016: 90 citations2017: 83 citations2018: 83 citations2019: 313 citations2020: 291 citations2021: 1,126 citations2022: 1,278 citations2023: 494 citations2024: 580 citations2025: 205 citations2026: 4 citations1929–1981: no citations, so these years are not shown1983–1986: no citations, so these years are not shown1989–1990: no citations, so these years are not shown1992–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,649 citing papers, 18.8% of this breakdownUnited Kingdom: 1,210 citing papers, 13.8% of this breakdownItaly: 441 citing papers, 5% of this breakdownChina: 404 citing papers, 4.6% of this breakdownCanada: 339 citing papers, 3.9% of this breakdownGermany: 324 citing papers, 3.7% of this breakdownAustralia: 285 citing papers, 3.3% of this breakdownFrance: 285 citing papers, 3.2% of this breakdownNetherlands: 258 citing papers, 2.9% of this breakdownSpain: 238 citing papers, 2.7% of this breakdownSweden: 177 citing papers, 2% of this breakdownSwitzerland: 157 citing papers, 1.8% of this breakdown
0%18.8%Other 34.3%

Fields

  • Medicine76%
  • Biochemistry, Genetics and Molecular Biology8.8%
  • Social Sciences3.2%
  • Mathematics2.6%
  • Immunology and Microbiology2.2%
  • Health Professions2%
  • Other5.2%

Topics

  • SARS-CoV-2 and COVID-19 Research10.4%
  • COVID-19 Clinical Research Studies6.2%
  • Vaccine Coverage and Hesitancy4.7%
  • COVID-19 epidemiological studies3%
  • Long-Term Effects of COVID-192.1%
  • Cervical Cancer and HPV Research1.8%
  • Other71.8%

Coauthors

All papers

Open in search
  1. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

    Authors: , , , , , , , , , , , , , , - BMJ 2021 cited by 1,395

  2. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection

    Authors: , , , , , , , , , , , , , , , , , , - Nature Medicine 2021 cited by 407

  3. Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2022 cited by 216

  4. Impact of healthcare-associated infection on length of stay

    Authors: , , , , , , , , , , , - Journal of Hospital Infection 2021 cited by 157

  5. Accelerated waning of the humoral response to COVID-19 vaccines in obesity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susanna Dunachie, Paul Klenerman, Adrian J. Park, Francesco Rubino, Abigail Lamikanra, Hannah Stark, Nathalie Kingston, Lise J Estcourt, Heli Harvala, David J. Roberts, Rainer Döffinger, Michelle A. Linterman, Nicholas J. Matheson, Aziz Sheikh, I. Sadaf Farooqi, James Thaventhiran - Nature Medicine 2023 cited by 100

  6. SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 cited by 301

  7. Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study

    Authors: , , , , , , - BMJ 2019 cited by 241

  8. SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness

    Authors: , , , - The Lancet 2021 cited by 1,065

  9. Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study

    Authors: , , , , , , , , , , - The Lancet Infectious Diseases 2017 cited by 264

  10. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David S. Goldberg, Paul McKeigue, Helen M. Colhoun, Alice E Whettlock, Allan McLeod, Andrew Gasiorowski, B. Alex Merrick, Andy McAuley, April Went, C. Purdie, Colin Fischbacher, Colin G. Ramsey, David Bailey, David Henderson, Eisin McDonald, Genna Drennan, G. Gowans, Graeme Reid, Heather Murdoch, Jade Carruthers, Josie Murray, Karen Heatlie, Lorraine Donaldson, Martin Paton, Martin Reid, Melissa Llano, Michelle Murphy-Hall, Ross S. Hall, Ross Cameron, S. Brownlie, Adam Gaffney, Aynsley Milne, Christopher Sullivan, Edward McArdle, Elaine Glass, Johanna Young, William Malcolm, J. McCoubrey - The Lancet Diabetes & Endocrinology 2020 cited by 341

  11. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chris Robertson, Aziz Sheikh - The Lancet 2021 cited by 604

  12. Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2020 cited by 137

  13. Prevalence and risk factors for long COVID among adults in Scotland using electronic health records: a national, retrospective, observational cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , - EClinicalMedicine 2024 cited by 35

  14. Diabetes and breast cancer risk: a meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , - British Journal of Cancer 2012 cited by 376

  15. Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels

    Authors: , , , , , , , , , , , , - Annals of Oncology 2002 cited by 502

  16. I-MOVE multicentre case–control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Eurosurveillance 2016 cited by 135

  17. Statistical Methods for the Prospective Detection of Infectious Disease Outbreaks: A Review

    Authors: , , , , - Journal of the Royal Statistical Society Series A (Statistics in Society) 2011 cited by 336

  18. Bed-days and costs associated with the inpatient burden of healthcare-associated infection in the UK

    Authors: , , , , , , , , , , , , - Journal of Hospital Infection 2021 cited by 72

  19. Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design

    Authors: , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2022 cited by 259

  20. Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales

    Authors: , , , , , , , , - BMC Medicine 2021 cited by 90

  21. Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2022 cited by 77

  22. Machine learning-enabled maternal risk assessment for women with pre-eclampsia (the PIERS-ML model): a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jing Li, Kenneth Lim, Sarka Lisonkova, Paula Lott, Jennifer M. Menzies, Alexandra Millman, Lynne Palmer, Beth A. Payne, Ziguang Qu, James A. Russell, Diane Sawchuck, Dorothy Shaw, Douglas K. Still, Ugochinyere Vivian Ukah, Brenda Wagner, Keith R. Walley, Dany Hugo, The late Andrée Gruslin, George Tawagi, Graeme N. Smith, Anne‐Marie Côté, Jean‐Marie Moutquin, Annie Ouellet, Shoo K. Lee, Tao Duan, Jian Zhou, The late Farizah Haniff, Swati Mahajan, Amanda Noovao, Hanna Karjalainend, Alja Kortelainen, Hannele Laivuori, J. Wessel Ganzevoort, Henk Groen, Phillipa M. Kyle, M. Peter Moore, Barbra Pullar, Zulfiqar A Bhutta, Rahat Qureshi, Rozina Sikandar, The late Shereen Z. Bhutta, Garth Cloete, David Hall, The late Erika van Papendorp, D.W. Steyn, Christine Biryabarema, Florence Mirembe, Annettee Nakimuli, John Allotey, Shakila Thangaratinam, K. H. Nicolaides, Olivia Ionescu, Argyro Syngelaki, Michael de Swiet, Laura A. Magee, Peter von Dadelszen, Ranjit Akolekar, James J. Walker, Stephen C. Robson, Fiona Broughton-Pipkin, Pamela Loughna, Manu Vatish, Christopher W.G. Redman, Sarah Barry, Kimberley Kavanagh, Tunde Montgomery-Csobán, Paul Murray, Chris Robertson, Eleni Tsigas, Douglas Woelkers and 5 more - The Lancet Digital Health 2024 cited by 42

  23. Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination: a population-based matched cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 36

  24. Depression and degree of acceptance of adjuvant cytotoxic drugs

    Authors: , , , , , - The Lancet 2000 cited by 353